Skip to content
★ Sign in to follow
JK

Jan K. Ohrstrom

Zymogenetics Inc
Total declarations
12
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (6 ops.)
€590k

Latest filing published 30 Mar 2007 for ZYMOGENETICS INC, €19k.

Insider track record

Disclosed buys
0
Disclosed sells
6
Signal history

No signal scores available.

Jan K. Ohrstrom: trading record in brief

Jan K. Ohrstrom discloses dealings in Zymogenetics Inc to SEC (Form 4). We count 12 filings; the first trade dates from 5 January 2006 and the latest from 28 March 2007.

No open-market purchase appears, only 6 sales worth €590k. Besides market trades, the filings include 6 option exercises. In 2007 alone, the filings show no purchases and 1 sale.

On 30 March 2007 came the latest disclosure, an option exercise for €19k in Zymogenetics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Jan K. Ohrstrom

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total
  • ◇
    Sr. VP, Business DevelopmentExecutivesZymogenetics Inc
    25,020 USD0SEC
    9,000 shares@ US$2.78Common StockSEC:0001209191-07-020606:0
  • ▼
    Sr. VP, Business DevelopmentExecutivesZymogenetics Inc
    137,700 USD0SEC
    9,000 shares@ US$15.30Common StockSEC:0001209191-07-020606:1
  • ◇
    Sr. VP, Business DevelopmentExecutivesZymogenetics Inc
    11,120 USD0SEC
    4,000 shares@ US$2.78Common StockSEC:0001209191-06-047549:0
  • ▼
    Sr. VP, Business DevelopmentExecutivesZymogenetics Inc
    80,160 USD0SEC
    4,000 shares@ US$20.04Common StockSEC:0001209191-06-047549:1
  • ◇
    Sr. VP, Commercial OperationsExecutivesZymogenetics Inc
    11,120 USD0SEC
    4,000 shares@ US$2.78Common StockSEC:0001181431-06-018122:0
  • ▼
    Sr. VP, Commercial OperationsExecutivesZymogenetics Inc
    87,000 USD0SEC
    4,000 shares@ US$21.75Common StockSEC:0001181431-06-018122:1
  • ◇
    Sr. VP, Commercial OperationsExecutivesZymogenetics Inc
    33,360 USD0SEC
    12,000 shares@ US$2.78Common StockSEC:0001181431-06-003500:0
  • ▼
    Sr. VP, Commercial OperationsExecutivesZymogenetics Inc
    271,920 USD0SEC
    12,000 shares@ US$22.66Common StockSEC:0001181431-06-003500:1
  • ◇
    Sr. VP, Commercial OperationsExecutivesZymogenetics Inc
    11,120 USD0SEC
    4,000 shares@ US$2.78Common StockSEC:0001181431-06-003142:0
  • ▼
    Sr. VP, Commercial OperationsExecutivesZymogenetics Inc
    80,040 USD0SEC
    4,000 shares@ US$20.01Common StockSEC:0001181431-06-003142:1
  • ◇
    Sr. VP, Commercial OperationsExecutivesZymogenetics Inc
    11,120 USD0SEC
    4,000 shares@ US$2.78Common StockSEC:0001181431-06-002529:0
  • ▼
    Sr. VP, Commercial OperationsExecutivesZymogenetics Inc
    72,000 USD0SEC
    4,000 shares@ US$18.00Common StockSEC:0001181431-06-002529:1

12 of 12 declarations